Cat. No. |
Product Name |
Information |
PC-21361 |
Compound 11064
DENV inhibitor
|
Compound 11064 is a baicalein-derived compound with potent activity against DENV and ZIKV, displays pan-serotype DENV and ZIKV antiviral activity in vitro in the low micromolar range. |
PC-38666 |
NITD008
Flavivirus inhibitor
|
NITD008 is a selective, adenosine-based flavivirus inhibitor, inhibits dengue virus (DENV, EC50= 0.64 μM), HCV and cellular entry of ZIKV, also has potent antiviral activity against EV71 with EC50 of 0.67 uM in cell culture. |
PC-38559 |
Filovirus inhibitor compd-A
Filovirus entry inhibitor
|
Filovirus inhibitor compd-A is a small molecule filovirus entry inhibitor targeting the endosomal receptor NPC1 binding site, shows potent inhibitory activity against both Ebola and Marburg viruses with IC50 of 0.86 uM against pseudotyped Marburg virus entry. |
PC-38463 |
ASN03576800
EBOV Vp40 inhibitor
|
ASN03576800 is a potent, small molecule inhibitor of matrix protein vp40 of ebola virus (EBOV), occupied the RNA binding region of VP40 with a Glide score of -7.66 and the Glide energy is -31.88 Kcal/mol. |
PC-35284 |
JBJ-16-111
|
JBJ-16-111 is a small molecule that inhibits dengue virus (DENV) by binding to its envelope protein E.. |
PC-35283 |
Compound 3-110-22
|
Compound 3-110-22 is a small molecule that inhibits dengue virus (DENV) by binding to its envelope protein E. |
PC-35009 |
JNJ-1A
|
JNJ-1A is a novel Dengue virus (DENV) NS4B inhibitor that inhibits DENV-2 sub-genomic replicon at 0.7 μM, in the absence of cytotoxicity. |
PC-35008 |
ST-148
|
ST-148 a novel potent, broad-spetrum inhibitor of dengue virus (DENV) replication, inhibits DENV-2 wth EC50 of 16 nM in viral titer reduction assays, interacts with the DENV Capsid protein. |
PC-35007 |
VGTI-A3-03
|
VGTI-A3-03 is a novel potent, highly virus-specific inhibitor of DENV replication with greatest activity against DENV serotype 2 (IC50=25 nM), directly bind DENV capsid protein. |
PC-63346 |
SFV785
|
SFV785 (SRPIN-785) is a derivative of SRPIN340 that selectively inhibits NTRK1 and MAPKAPK5 kinase, shows anti-viral activity on HCV, DENV and yellow fever viruses. |
PC-62053 |
FGI-106
|
FGI-106 is a broad-spectrum inhibitor of multiple blood-borne viruses (HCV, HBV, HIV) as well as emerging biothreats (Ebola, VEE, Cowpox, PRRSV infection) with EC50 of 0.2-10 uM. |
PC-62052 |
FGI-104
|
FGI-104 is a small-molecule inhibitor of filovirus that exhibits potent antiviral activity against of EBOV (EC90=330 nM, ZEBOV) and MARV (EC50=2.5 uM, MARV-Ci67). |